Effects of poly(2-hydroxyethyl methacrylate) and poly(vinyl-pyrrolidone) hydrogel implants on myopic and normal chick sclera.
There has been generally little attention paid to the utilization of biomaterials as an anti-myopia treatment. The purpose of this study was to investigate whether polymeric hydrogels, either implanted or injected adjacent to the outer scleral surface, slow ocular elongation. White Leghorn (Gallus gallus domesticus) chicks were used at 2 weeks of age. Chicks had either (1) a strip of poly(2-hydroxyethyl methacrylate) (pHEMA) implanted monocularly against the outer sclera at the posterior pole, or (2) an in situ polymerizing gel [main ingredient: poly(vinyl-pyrrolidone) (PVP)] injected monocularly at the same location. Some of the eyes injected with the polymer were fitted with a diffuser or a -10D lens. In each experiment, ocular lengths were measured at regular intervals by high frequency A-scan ultrasonography, and chicks were sacrificed for histology at staged intervals. No in vivo signs of either orbital or ocular inflammation were observed. The pHEMA implant significantly increased scleral thickness by the third week, and the implant became encapsulated with fibrous tissue. The PVP-injected eyes left otherwise untreated, showed a significant increase in scleral thickness, due to increased chondrocyte proliferation and extracellular matrix deposition. However, there was no effect of the PVP injection on ocular elongation. In eyes wearing optical devices, there was no effect on either scleral thickness or ocular elongation. These results represent "proof of principle" that scleral growth can be manipulated without adverse inflammatory responses. However, since neither approach slowed ocular elongation, additional factors must influence scleral surface area expansion in the avian eye.
Su
James
J
Vision Science Group, School of Optometry, UC Berkeley, Berkeley, CA 94720-2020, USA. james_su@berkeley.edu
Iomdina
Elena
E
Tarutta
Elena
E
Ward
Brian
B
Song
Jie
J
Wildsoet
Christine F
CF
D000818:Animals; D001672:Biocompatible Materials; D002645:Chickens; D019902:Chondrocytes / Q000473:pathology; D004195:Disease Models, Animal; D005123:Eye / Q000254:growth & development; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D009216:Myopia / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D011102:Polyhydroxyethyl Methacrylate / Q000031:analogs & derivatives; D011205:Povidone; D019736:Prostheses and Implants; D012590:Sclera / Q000254:growth & development / Q000473:pathology
D001672:Biocompatible Materials; D011102:Polyhydroxyethyl Methacrylate; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; C023037:poly(2-hydroxyethyl acrylate); D011205:Povidone